Covid: Booster promising against Omicron variant – Pfizer/BioNTech

Pfizer and BioNTech have said a booster jab of their coronavirus vaccine promises to be an effective defence against the new Omicron variant.

Three doses provide a similar level of antibodies against Omicron to that of two doses with other variants, the companies said after a small study.

• We’ve not recorded community transmission of Omicron variant yet – Dr. Kuma-Aboagye
• Pfizer, BioNTech submit Covid-19 booster vaccine data to FDA

The World Health Organization (WHO) earlier said vaccines should still work against severe Omicron cases.

Researchers across the world are piecing together data about Omicron.